Research - News
The grant is being used to fund a first-of-its-kind clinical trial that will recruit healthy individuals through a “genome-first” approach and perform deep metabolic phenotyping to understand the underlying mechanisms responsible for the regulation of the human body’s metabolism through natriuretic peptide hormones.
To facilitate gene-level queries of data from more than 10,000 cancer patient transcriptome sequences and proteomics data from 2,000 patients, researchers have developed a user-friendly cancer data analysis web platform called UALCAN.